Latest filing published 06 Jun 2013 for Epizyme, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Astellas Venture Fund I L.P.: trading record in brief
Astellas Venture Fund I L.P. appears in our data through filings on Epizyme, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated 5 June 2013.
No open-market sale appears; the market trades are 1 purchase worth €176k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 6 June 2013 came the latest disclosure, a transaction in Epizyme, Inc. The last insider purchase was made public on 6 June 2013, 4,904 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Astellas Venture Fund I L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 634,920 sharesCommon StockSEC:0001181431-13-033331:0
- 15,333 shares@ US$15.00Common StockSEC:0001181431-13-033331:1Canonical exit: 3 Sept 2013 (T+90)
2 of 2 declarations
